|
Patient
|
RA disease
|
RF
|
CRP
|
steroid
|
DMARDs
|
|---|
|
no.
|
duration (years)
|
(Unit/mL)
|
(mg/dL)
|
(mg/day)
| |
|---|
|
1
|
21
|
172
|
3.3
|
10
|
MTX 6 mg/week
|
|
2
|
24
|
99
|
2.0
|
5
|
Bucillamine 100 mg/day, MTX 4 mg/week
|
|
3
|
40
|
507
|
3.3
|
0
|
Actarit 200 mg/day
|
|
4
|
45
|
49
|
0.3
|
0
| |
|
5
|
9
|
324
|
2.6
|
4
| |
|
6
|
16
|
13
|
1.4
|
2.5
|
Bucillamine 100 mg/day
|
|
7
|
2
|
242
|
4.4
|
7.5
|
Salazosulfapyridine 1000 mg/day, MTX 6 mg/week
|
|
8
|
24
|
98
|
0.9
|
0
|
MTX 4 mg/week
|
|
9
|
17
|
40
|
2.9
|
5
|
MTX 6 mg/week
|
- CRP, C-reactive protein; DMARDs, disease-modifying antirheumatic drugs; MTX, methotrexate;
- RA, rheumatoid arthritis; RF, rheumatoid factor.
